ATTN LogoMenu
4TGTXTier 4
Articles

TG THERAPEUTICS, INC. 4

0001437749-26-026608

View on SEC EDGAR

Laurence N. Charney, an insider of TG Therapeutics, Inc. (TGTX), gifted a total of 6,050 shares of common stock to a 501(c)(3) institution over August 6–7, 2026.

On August 6 and 7, 2026, Laurence N. Charney, an insider of TG Therapeutics, Inc., made a series of bona fide gifts of the company’s common stock to a 501(c)(3) institution, transferring 5,100 shares on August 6 and an additional 500 and 450 shares on August 7, with no sale proceeds received and no retained beneficial or pecuniary interest in the donated shares. Following these charitable transfers, Charney’s direct holdings in TG Therapeutics common stock decreased from 179,690 shares before the first gift to 173,640 shares after the final gift, inclusive of restricted stock that vests over various periods. The transactions reflect philanthropic activity rather than open-market trading and do not indicate a change in the insider’s economic view of the company.

Filing Facts

CIK
1001316
Ticker
TGTX
Form
4
Source Type
fda
Accession
0001437749-26-026608
Alert Tier
4
TG THERAPEUTICS, INC. 4 | ATTN